Our characterization of the regulatory elements that drive the SMC-selective expression of Prdm6 should add to our understanding of DA development and the mechanisms by which cardiovascular disease–associated variations within the Prdm6 affect its expression. Here, PRDM6 is linked to cardiovascular disorder.